Cover Image
市場調查報告書

Colby Pharmaceutical Company :產品平台分析

Colby Pharmaceutical Company - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251681
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Colby Pharmaceutical Company :產品平台分析 Colby Pharmaceutical Company - Product Pipeline Review - 2015
出版日期: 2015年06月17日 內容資訊: 英文 28 Pages
簡介

Colby Pharmaceutical Company 是製造治療癌症和感染疾病,發炎性疾病,疼痛等生物製藥及小分子藥的製藥公司。

本報告提供Colby Pharmaceutical Company 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Colby Pharmaceutical Company的基本資料

  • Colby Pharmaceutical Company概要
  • 主要資訊
  • 企業資料

Colby Pharmaceutical Company :R&D概要

  • 主要的治療範圍

Colby Pharmaceutical Company :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Colby Pharmaceutical Company :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Colby Pharmaceutical Company :開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Colby Pharmaceutical Company :藥物簡介

  • CPC-1001
  • JVRS-100
  • CPC-410
  • JVRS-100 + Herpes Simplex Virus-2 Vaccine
  • JVRS-100 + Universal Influenza Vaccine
  • JVRSOD
  • JVRS-100 + HBV Vaccine
  • JVRS-100 + Malaria Vaccine
  • CPC-507
  • CPC-703

Colby Pharmaceutical Company :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Colby Pharmaceutical Company :最近的開發平台趨勢

Colby Pharmaceutical Company :暫停中的計劃

Colby Pharmaceutical Company :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07180CDB

Summary

Global Markets Direct's, 'Colby Pharmaceutical Company - Product Pipeline Review - 2015', provides an overview of the Colby Pharmaceutical Company's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Colby Pharmaceutical Company including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Colby Pharmaceutical Company's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Colby Pharmaceutical Company's pipeline products

Reasons to buy

  • Evaluate Colby Pharmaceutical Company's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Colby Pharmaceutical Company in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Colby Pharmaceutical Company's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Colby Pharmaceutical Company and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Colby Pharmaceutical Company
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Colby Pharmaceutical Company and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Colby Pharmaceutical Company Snapshot
    • Colby Pharmaceutical Company Overview
    • Key Information
    • Key Facts
  • Colby Pharmaceutical Company - Research and Development Overview
    • Key Therapeutic Areas
  • Colby Pharmaceutical Company - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Colby Pharmaceutical Company - Pipeline Products Glance
    • Colby Pharmaceutical Company - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Colby Pharmaceutical Company - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Colby Pharmaceutical Company - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Colby Pharmaceutical Company - Drug Profiles
    • CPC-551
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JVRS-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • JVRSOD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Prostate Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CPC-123
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Colby Pharmaceutical Company - Pipeline Analysis
    • Colby Pharmaceutical Company - Pipeline Products by Target
    • Colby Pharmaceutical Company - Pipeline Products by Route of Administration
    • Colby Pharmaceutical Company - Pipeline Products by Molecule Type
    • Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action
  • Colby Pharmaceutical Company - Recent Pipeline Updates
  • Colby Pharmaceutical Company - Dormant Projects
  • Colby Pharmaceutical Company - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Colby Pharmaceutical Company, Key Information
  • Colby Pharmaceutical Company, Key Facts
  • Colby Pharmaceutical Company - Pipeline by Indication, 2015
  • Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
  • Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
  • Colby Pharmaceutical Company - Phase II, 2015
  • Colby Pharmaceutical Company - Phase I, 2015
  • Colby Pharmaceutical Company - Preclinical, 2015
  • Colby Pharmaceutical Company - Unknown, 2015
  • Colby Pharmaceutical Company - Pipeline by Target, 2015
  • Colby Pharmaceutical Company - Pipeline by Route of Administration, 2015
  • Colby Pharmaceutical Company - Pipeline by Molecule Type, 2015
  • Colby Pharmaceutical Company - Pipeline Products by Mechanism of Action, 2015
  • Colby Pharmaceutical Company - Recent Pipeline Updates, 2015
  • Colby Pharmaceutical Company - Dormant Developmental Projects,2015
  • Colby Pharmaceutical Company, Subsidiaries

List of Figures

  • Colby Pharmaceutical Company - Pipeline by Top 10 Indication, 2015
  • Colby Pharmaceutical Company - Pipeline by Stage of Development, 2015
  • Colby Pharmaceutical Company - Monotherapy Products in Pipeline, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Target, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Route of Administration, 2015
  • Colby Pharmaceutical Company - Pipeline by Top 10 Molecule Type, 2015
  • Colby Pharmaceutical Company - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top